Ambler class |
Protein name |
PDB code |
Resolution (Å) |
Release date |
UniProt code |
PubMed ID |
DOI |
PDB |
Mutations |
Ligands |
Space group |
Unit cell parameters |
Z value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ||||||||
B1 | VIM-4 | 2WHG | 1.90 | 2010-05-19 | Q70E11 | 21149620 | 10.1128/AAC.01486-09 | pdb | FLC ZN | C 1 2 1 | 141.390 46.220 105.990 ♦ 90.00 105.24 90.00 | 8 | |
B1 | VIM-4 | 2WRS | 2.79 | 2010-06-23 | Q70E11 | 20527888 | 10.1021/JM100213C | pdb | CIT FLC ZN | C 1 2 1 | 140.130 45.670 105.030 ♦ 90.00 105.41 90.00 | 8 |
Statistics (number of structures): Overall (1663); class A (626); subclass B1 (403); subclass B2 (16); subclass B3 (104); class C (246); class D (268).
Last updated: November 20, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu